Get the Stockscreener App
513.03
1.44%
7.28
After Hours:
511.50
-1.53
-0.30%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $513.03, with a volume of 4.56M.
It is up +1.44% in the last 24 hours and up +14.47% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$505.75
Open:
$509.73
24h Volume:
4.56M
Relative Volume:
2.03
Market Cap:
$190.65B
Revenue:
$45.20B
Net Income/Loss:
$6.87B
P/E Ratio:
28.21
EPS:
18.1888
Net Cash Flow:
$6.75B
1W Performance:
+10.42%
1M Performance:
+14.47%
6M Performance:
-11.66%
1Y Performance:
+24.49%
1-Day Range:
$499.56
$514.80
1-Week Range:
$458.91
$515.96
52-Week Range:
$401.45
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
513.03 | 190.65B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 138.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.50B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.41B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.51B | 2.50B | -226.32M | 71.51M | -1.6412 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | DZ Bank | Buy |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher outlines capital plans for 2030, shares tracked against S&P 500 peers - Ad-hoc-news.de
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage - Insider Monkey
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOD) - TradingView
The Axion M200 from Thermo Fisher Scientific Inc.compact microscope for crowded benchtops - Ad-hoc-news.de
Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning - Ad-hoc-news.de
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOC) - TradingView
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com Canada
Thermo Fisher Scientific (TMO) Stock After Recent Volatility Is The Current Price Reasonable - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Is Thermo Fisher (TMO) Quietly Redefining Its Edge With AI-Enabled, End-to-End Biopharma Tools? - Yahoo Finance Singapore
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.23% on Jun 25: Key Drivers Unveiled - TradingKey
Thermo Fisher Scientific Inc. Actuals & Estimates (NYSE:TMO) - TradingView
Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Thermo Fisher gains as investors weigh growth targets, Clario integration, and fresh analyst support - Quiver Quantitative
Thermo Fisher Scientific’s Dr Anil Kane Discusses How AI and Strategic Partnerships Are Reshaping Contract Drug Development at BIO 2026 - BioPharm International
TMO Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Thermo Fisher Scientific Inc – NYSE:TMO - TradingView
Thermo Fisher breaks through a fresh 52-week high, shares extend the S&P 500 run - Ad-hoc-news.de
Thermo Fisher Scientific (TMO) Showcases AI Tools As Fair Value Narrative Stays In Focus - Sahm
Thermo Fisher Scientific Inc (TMO) Stock Up 4.9% and Still Under - GuruFocus
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Is Down 27% From Its Highs. The EPS Trough Looks Like It Is Already Behind the Company - TIKR.com
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.84% on Jun 24: What Investors Need To Know - TradingKey
Thermo Fisher (NYSE:TMO) Draws Attention With Expanding AI Strategy - Kalkine Media
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage? - Insider Monkey
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
With EPS Growth And More, Thermo Fisher Scientific (NYSE:TMO) Makes An Interesting Case - Moomoo
Thermo Fisher highlights AI research tools at BIO International, shares steady on NYSE - Ad-hoc-news.de
Can Unread Emails Trigger Arbitration? 9th Circ. Airs Doubts - Law360
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026 - BioSpace
Thermo Fisher (TMO) to Highlight Innovations at BIO Internationa - GuruFocus
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 28.97% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Thermo Fisher Scientific launches PPD CorEvitas Chronic Hand Eczema Registry - Select Science
Thermo Fisher Scientific’s latest mass spec innovations: new Orbitrap, AI capabilities, and complete workflows - Select Science
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Why Is Thermo Fisher Scientific Stock Drawing Attention Right Now? - Kalkine Media
Piper Sandler Initiates Coverage of Thermo Fisher Scientific (TMO) with a Neutral View - Yahoo Finance
Thermo Fisher Scientific, Inc.: - marketscreener.com
Is Thermo Fisher Scientific stock underperforming the S&P 500? - MSN
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Tests SpheriCal Calibration As Potential Edge In Mass Spectrometry - Yahoo Finance
Xponance LLC Buys 4,436 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Swiss National Bank - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stake Cut by Polen Capital Management LLC - MarketBeat
ICICI Prudential Asset Management Co Ltd Trims Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
UniSuper Management Pty Ltd Sells 5,100 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Purchased by Nuveen LLC - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):